Position in GMED
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$66,673,537
+$32,995,169 QoQ
Shares Held
773,834
+68.2% QoQ
Ownership
0.570%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GMED Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Holocene Advisors, LP holds $844,866,051 across 15 Medical Devices names. GMED ranks #5 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
3,428,736 | $215,153,184 | |
| 2 | GKOS |
GLAUKOS Corp
|
1,383,715 | $148,970,756 | |
| 3 | IRTC |
iRhythm Holdings, Inc.
|
1,248,658 | $147,366,617 | |
| 4 | ABT |
Abbott Laboratories
|
790,916 | $81,203,345 | |
| 5 | GMED |
Globus Medical Inc
This page
|
773,834 | $66,673,537 | |
| 6 | EW |
Edwards Lifesciences Corp
|
738,099 | $59,106,967 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
593,705 | $53,682,806 | |
| 8 | PEN |
Penumbra Inc
|
110,614 | $36,322,319 |
All Filings in GMED
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,673,537 | 773,834 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $33,678,368 | 460,087 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $7,311,014 | 137,193 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,148,555 | 83,556 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,826,949 | 131,457 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $898,706 | 15,867 | Shares | Sole | 2023-05-15 | |
| 2021-03-31 | $659,313 | 10,691 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $505,194 | 7,746 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||